Unknown

Dataset Information

0

An Open-label, Multicenter Study to Assess the Efficacy and Safety of a Novel Probiotic Blend in Patients With Functional Gastrointestinal Symptoms.


ABSTRACT:

Goal

A novel 5-strain (Bl-04, Bi-07, HN019, NCFM, and Lpc-37) probiotic blend was developed and its safety and efficacy were evaluated in patients with functional gastrointestinal (GI) symptoms.

Background

These strains administered together have not previously been investigated.

Study

Patients aged 18 to 75 years with functional GI symptoms were eligible for inclusion in a single-arm, open-label, multicenter study (NCT04155801). An oral capsule containing the novel probiotic blend was administered once daily for 30 days. The primary efficacy endpoint was patient-reported improvement in overall GI well-being at day 30. Secondary efficacy endpoints included changes in GI symptoms assessed using the GI Health Symptom Questionnaire. Incidence of treatment-emergent adverse events was recorded at all visits.

Results

Of 188 enrolled patients, 72.3% were female and mean (SD) age was 44.1 (13.4) years. At day 30, 85.1% of patients achieved the primary endpoint, a positive response signifying improvement in overall GI well-being. Improvements from baseline were reported at day 30 in diarrhea frequency (baseline frequency≥3 to 4 d/wk) and severity (baseline severity≥5/10) for 75.8% and 87.3% of patients, respectively. Over the same time period, constipation frequency (baseline frequency≥3 to 4 d/wk) and severity (baseline severity≥5/10) improved in 73.6% and 80.4% of patients, respectively. Most patients reported improvements at day 30 in frequency and severity of straining, urgency, abdominal pain/discomfort, bloating, and distention. Improvements reported at day 30 were generally observable at day 14. No safety signals were identified.

Conclusion

A novel 5-strain probiotic blend improved functional GI symptoms and was safe.

SUBMITTER: Harris LA 

PROVIDER: S-EPMC8989638 | biostudies-literature | 2022 May-Jun 01

REPOSITORIES: biostudies-literature

altmetric image

Publications

An Open-label, Multicenter Study to Assess the Efficacy and Safety of a Novel Probiotic Blend in Patients With Functional Gastrointestinal Symptoms.

Harris Lucinda A LA   Cash Brooks D BD   Moftah Karim K   Franklin Howard H  

Journal of clinical gastroenterology 20220501 5


<h4>Goal</h4>A novel 5-strain (Bl-04, Bi-07, HN019, NCFM, and Lpc-37) probiotic blend was developed and its safety and efficacy were evaluated in patients with functional gastrointestinal (GI) symptoms.<h4>Background</h4>These strains administered together have not previously been investigated.<h4>Study</h4>Patients aged 18 to 75 years with functional GI symptoms were eligible for inclusion in a single-arm, open-label, multicenter study (NCT04155801). An oral capsule containing the novel probiot  ...[more]

Similar Datasets

| S-EPMC9907038 | biostudies-literature
| S-EPMC3312066 | biostudies-other
| S-EPMC5507560 | biostudies-literature
| S-EPMC11478705 | biostudies-literature
| S-EPMC9449923 | biostudies-literature
| S-EPMC3489792 | biostudies-literature
| S-EPMC11762568 | biostudies-literature
| S-EPMC7937426 | biostudies-literature
| S-EPMC11328082 | biostudies-literature
| S-EPMC9662900 | biostudies-literature